Antimicrobial Peptide Pro10-1D Exhibits Anti-Allergic Activity: A Promising Therapeutic Candidate
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252212138 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Min Yeong Choi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, College of Medicine, Konkuk University, Chungju 27478, Republic of Korea. Hauptthemen laut MEDLINE: Mast Cells, Anti-Allergic Agents. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Research Foundation of Korea, National Research Foundation of Korea (NRF) grant, Korea National Institute of Health (KNIH) research project.
Abstract (Originalsprache)
Although antimicrobial peptides (AMPs) exhibit a range of biological functions, reports on AMPs with therapeutic effects in allergic disorders are limited. In this study, we investigated the anti-allergic effects of Pro10-1D, a 10-meric AMP derived from insect defensin protaetiamycine. Our findings demonstrate that Pro10-1D effectively inhibits antigen-induced degranulation of mast cells (MCs) with IC50 values of approximately 11.6 μM for RBL-2H3 cells and 2.7 μM for bone marrow-derived MCs. Furthermore, Pro10-1D suppressed the secretion of cytokines with IC50 values of approximately 2.8 μM for IL-4 and approximately 8.6 μM for TNF-α. Mechanistically, Pro10-1D inhibited the Syk-LAT-PLCγ1 signaling pathway in MCs and decreased the activation of mitogen-activated protein kinases (MAPKs). Pro10-1D demonstrated a dose-dependent reduction in IgE-mediated passive cutaneous anaphylaxis in mice with an ED50 value of approximately 7.6 mg/kg. Further investigation revealed that Pro10-1D significantly reduced the activity of key kinases Fyn and Lyn, which are critical in the initial phase of the FcεRI-mediated signaling pathway, with IC50 values of approximately 22.6 μM for Fyn and approximately 1.5 μM for Lyn. Collectively, these findings suggest that Pro10-1D represents a novel therapeutic candidate for the treatment of IgE-mediated allergic disorders by targeting the Lyn/Fyn Src family kinases in MCs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology, College of Medicine, Konkuk University, Chungju 27478, Republic of Korea.
- Department of Bioscience and Biotechnology, Konkuk University, Seoul 05029, Republic of Korea.
- Institute of Biomedical Sciences & Technology, Konkuk University, Seoul 05029, Republic of Korea.
ORCID-Profile: Yangmee Kim
Förderung
- the National Research Foundation of Korea
- National Research Foundation of Korea (NRF) grant
- Korea National Institute of Health (KNIH) research project
Zitieren
APA
Choi, M. Y., Jo, M. G., Min, K. Y., Kim, B., Kim, Y., & Choi, W. S. (2024). Antimicrobial Peptide Pro10-1D Exhibits Anti-Allergic Activity: A Promising Therapeutic Candidate. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252212138
Vancouver
Choi MY, Jo MG, Min KY, Kim B, Kim Y, Choi WS. Antimicrobial Peptide Pro10-1D Exhibits Anti-Allergic Activity: A Promising Therapeutic Candidate. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252212138
BibTeX
@article{Choi2024,
author = {Choi, Min Yeong and Jo, Min Geun and Min, Keun Young and Kim, Byeongkwon and Kim, Yangmee and Choi, Wahn Soo},
title = {Antimicrobial Peptide Pro10-1D Exhibits Anti-Allergic Activity: A Promising Therapeutic Candidate},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252212138}
}
EUVIMED